The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Abbott Laboratories shares valued at $337,116 were sold by Blount Sally E. on Apr 30 ’25. At $129.66 per share, Blount Sally E. sold 2,600 shares. The insider’s holdings dropped to 34,058 shares worth approximately $4.3 million following the completion of this transaction.
Before that, Earnhardt Lisa D had sold 91,167 shares from its account. In a trade valued at $12,199,968, the EVP AND GROUP PRESIDENT traded Abbott Laboratories shares for $133.82 each. Upon closing the transaction, the insider’s holdings decreased to 91,167 shares, worth approximately $9.08 million.
As published in a research note from Jefferies on July 18, 2025, Abbott Laboratories [ABT] has been rated up from a Hold to a Buy and the price target has been revised to $145. Analysts at Leerink Partners started covering the stock with ‘”a Market perform”‘ outlook in a report released in mid June. As of October 08, 2024, Oppenheimer has initiated its “an Outperform” rating for ABT. Earlier on September 19, 2024, Piper Sandler initiated its rating. Their recommendation was “an Overweight” for ABT stock.
Analyzing ABT Stock Performance
On last trading session, Abbott Laboratories [NYSE: ABT] plunged -1.84% to $126.19. The stock’s lowest price that day was $125.81, but it reached a high of $129.15 in the same session. During the last five days, there has been a surge of approximately 0.44%. Over the course of the year, Abbott Laboratories shares have jumped approximately 20.44%. Shares of the company reached a 52-week high of $141.23 on 03/04/25 and a 52-week low of $110.86 on 01/15/25.
Support And Resistance Levels for Abbott Laboratories (ABT)
According to the 24-hour chart, there is a support level at 124.95, which, if violated, would cause prices to drop to 123.71. In the upper region, resistance lies at 128.29. The next price resistance is at 130.39. RSI (Relative Strength Index) is 41.28 on the 14-day chart, showing neutral technical sentiment.
Is Abbott Laboratories subject to short interest?
Stocks of Abbott Laboratories saw a sharp steep in short interest on 2025-07-15 dropping by -1.74 million shares to 19.06 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 20.8 million shares. A decline of -9.14% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.12 of the overall float, the days-to-cover ratio (short ratio) decline to 3.12.
Which companies own the most shares of Abbott Laboratories (ABT)?
In terms of Abbott Laboratories share price expectations, FactSet research, analysts set an average price target of 147 in the next 12 months, up nearly 14.35% from the previous closing price of $128.55. Analysts anticipate Abbott Laboratories stock to reach 147 by 2025, with the lowest price target being 147. In spite of this, 13 analysts ranked Abbott Laboratories stock as Buy at the end of 2025.